Trial intelligence / Profile preview

Tranexamic acid in intracerebral haemorrhage

ISRCTN50867461Phase 2Completed

Sponsor
University of Nottingham
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of tranexamic acid in intracerebral hemorrhage (ICH) (2 arms), sponsored by University of Nottingham. Primary endpoints: Acceptability and Tolerability. Started Dec 2010; status: completed.

02

Drugs

tranexamic acid
03

Conditions

intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on ISRCTN50867461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN50867461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call